drugset / Trial / NCT01423864

Intrapleural Methylprednisolone Injection for Multiple Organ Failure With Acute Respiratory Distress Syndrome

NCT01423864

Phase 2 Completed 29 enrolled National Taiwan University Hospital
Non-randomizedParallel-groupOpen-labelTreatment

Summary

Acute respiratory distress syndrome (ARDS) in combination with multi-organ dysfunction syndrome (MODS) is a life-threatening condition, particularly when treatment modalities such as extracorporeal membrane oxygenation (ECMO) and catecholamine administration have failed to treat the severe condition. In this study, the investigators report patients who responded to intrapleural steroid instillation (IPSI) while being unresponsive to conventional treatment (use of intravenous steroids, nitric oxide inhalation, high-frequency oscillatory ventilation, or ECMO) for treatment of critical illnesses such as ARDS in combination with MODS.

Timeline

Start
2005-06
Primary completion
2009-06
Completion
2009-06

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Hydrocortisone Other / unclassified 50 mg Intravenous
Subject Methylprednisolone Other / unclassified 40 mg Other